Mecwins Welcomes Almenara Capital Partners and Potential Investors to Its Headquarters in Tres Cantos
This week, Mecwins had the pleasure of welcoming representatives [...]
Roche’s FDA-Cleared Blood Test for Alzheimer’s: A Milestone for the Entire Neurodiagnostics Community
The recent announcement that Roche Diagnostics USA has received FDA [...]
Mecwins Selected by Almenara Capital Partners for Its New LifeTech Innovation Fund Portfolio
We are pleased to share that Mecwins has [...]
Destina Genomics Appoints New CEO as Mecwins Strengthens Partnership
Destina Genomics, a biotechnology company specializing in advanced [...]
Leader in Cardiology Joins as Scientific Advisor to Support Our Clinical Solutions
We’re thrilled to welcome Dr. Rio Aguilar Torres [...]
Mecwins Achieves DNSH Certification, Reinforcing Commitment to Sustainability
We are proud to announce that our company has [...]
Immunosensor Research to the Next Level
Following our recent publication on improving immunosensor performance through [...]
Mecwins Joins the Enterprise Europe Network with New Profile on Scientific Instrumentation
Mecwins is proud to announce the publication of [...]
